SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI)
CRIS 1.150-1.7%3:55 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Evans who wrote (211)7/22/1999 9:43:00 AM
From: Thomas Stewart  Read Replies (2) of 668
 
PMA accepted. Why has this news fallen on deaf ears?

Stryker's OP-1 Implant(TM) PMA Submission Accepted for Filing
KALAMAZOO, Mich., July 21 /PRNewswire/ -- Stryker Corporation (NYSE: SYK - news) announced today that the Pre-Market Approval (PMA) submission for its OP-1 Implant(TM) has been accepted for filing by the U.S. Food and Drug Administration (FDA). The PMA submission seeks approval for the OP-1 Implant(TM) to treat long bone nonunions. The Company can give no assurance that approval for any use of the OP-1 Implant(TM) will be obtained.

Stryker Corporation develops, manufactures and markets specialty surgical and medical products, including orthopaedic reconstructive, trauma and spinal implants, powered surgical instruments, endoscopic systems, patient care and handling equipment for the global market and provides outpatient physical therapy services in the United States.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext